Jian Hua Mo
Directeur/Membre du Conseil chez HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Fortune : 173 M $ au 30/04/2024
Postes actifs de Jian Hua Mo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Directeur/Membre du Conseil | 01/05/2012 | - |
| Corporate Officer/Principal | 01/01/2003 | 01/05/2012 | |
| BINJIANG SERVICE GROUP CO. LTD. | Directeur/Membre du Conseil | 01/12/2017 | - |
| Shanghai Binshun Investment Management Ltd | Directeur/Membre du Conseil | - | - |
| Hangzhou Binpu Real Estate Development Ltd. | Directeur/Membre du Conseil | - | - |
| Corporate Officer/Principal | - | - | |
| Hangzhou Pute Equity Investment Management Ltd. | Corporate Officer/Principal | 01/01/2017 | - |
Historique de carrière de Jian Hua Mo
Anciens postes connus de Jian Hua Mo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Hangzhou Binjiang Venture Captal Investment Ltd. | Corporate Officer/Principal | 01/05/2011 | 01/11/2017 |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. | Corporate Officer/Principal | 01/08/1996 | 01/12/1999 |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Directeur/Membre du Conseil | 08/04/2011 | - |
Formation de Jian Hua Mo
| Zhejiang University | Masters Business Admin |
Statistiques
Internationale
| Chine | 9 |
| Îles Cayman | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Corporate Officer/Principal | 5 |
| Masters Business Admin | 1 |
Sectorielle
| Finance | 3 |
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| BINJIANG SERVICE GROUP CO. LTD. | Finance |
| Entreprise privées | 6 |
|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Shanghai Binshun Investment Management Ltd | |
| Hangzhou Binpu Real Estate Development Ltd. | |
| Hangzhou Pute Equity Investment Management Ltd. | |
| Hangzhou Binjiang Venture Captal Investment Ltd. | |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. |
- Bourse
- Insiders
- Jian Hua Mo
- Expérience
